Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fuji
Accenture
Daiichi Sankyo
Moodys
Mallinckrodt
Medtronic
Chubb
Chinese Patent Office
Teva

Generated: August 21, 2017

DrugPatentWatch Database Preview

Levonorgestrel - Generic Drug Details

« Back to Dashboard

What are the generic sources for levonorgestrel and what is the scope of levonorgestrel freedom to operate?

Levonorgestrel
is the generic ingredient in fourteen branded drugs marketed by Novel Labs Inc, Bayer Hlthcare, Wyeth Pharms Inc, Lupin Ltd, Medicines360, Perrigo R And D, Sun Pharm Inds Ltd, Mylan Labs Ltd, Population Council, Glenmark Pharms Ltd, Teva Branded Pharm, Reckitt Benckiser, Watson Labs, Aurobindo Pharma Ltd, Watson Labs Inc, Novast Labs Ltd, Oc Pharma, and Lotus Pharm Co Ltd, and is included in twenty-seven NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Levonorgestrel has forty-eight patent family members in twenty-six countries.

There are twenty drug master file entries for levonorgestrel. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: levonorgestrel

Tradenames:14
Patents:3
Applicants:18
NDAs:27
Drug Master File Entries: see list20
Suppliers / Packagers: see list28
Bulk Api Vendors: see list44
Clinical Trials: see list169
Patent Applications: see list5,201
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levonorgestrel at DailyMed

Pharmacology for Ingredient: levonorgestrel

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
OPCICON ONE-STEP
levonorgestrel
TABLET;ORAL202635-001Sep 11, 2014OTCNoNo► Subscribe► Subscribe► Subscribe
Population Council
NORPLANT
levonorgestrel
IMPLANT;IMPLANTATION019897-001Dec 10, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Branded Pharm
PLAN B
levonorgestrel
TABLET;ORAL021045-001Jul 28, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
LEVONORGESTREL
levonorgestrel
TABLET;ORAL200670-001Jul 12, 2012OTCNoNo► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
KYLEENA
levonorgestrel
INTRAUTERINE DEVICE;INTRAUTERINE208224-001Sep 16, 2016RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: levonorgestrel

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Population Council
NORPLANT
levonorgestrel
IMPLANT;IMPLANTATION019897-001Dec 10, 1990► Subscribe► Subscribe
Bayer Hlthcare
MIRENA
levonorgestrel
INTRAUTERINE DEVICE;INTRAUTERINE021225-001Dec 6, 2000► Subscribe► Subscribe
Bayer Hlthcare
SKYLA
levonorgestrel
INTRAUTERINE DEVICE;INTRAUTERINE203159-001Jan 9, 2013► Subscribe► Subscribe
Population Council
NORPLANT
levonorgestrel
IMPLANT;IMPLANTATION019897-001Dec 10, 1990► Subscribe► Subscribe
Wyeth Pharms Inc
NORPLANT SYSTEM IN PLASTIC CONTAINER
levonorgestrel
IMPLANT;IMPLANTATION020088-001Dec 10, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: levonorgestrel

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,452,082Inserter► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: levonorgestrel

Country Document Number Estimated Expiration
CroatiaP20130510► Subscribe
Mexico2011002670► Subscribe
Japan4382668► Subscribe
Brazil0314287► Subscribe
World Intellectual Property Organization (WIPO)2004026196► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: LEVONORGESTREL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
2015000093Germany► SubscribePRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
156Luxembourg► SubscribePRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Dow
Harvard Business School
UBS
Novartis
Argus Health
Boehringer Ingelheim
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot